Blog
RSS FeedPosted by Michael Wonder on 03 Dec 2020
The real worth of cancer drugs
1 December 2020 - In November, 2020, we witnessed one of the most awaited elections in recent times—the USA elected Joe ...
Posted by Michael Wonder on 03 Dec 2020
Protagonist's hepcidin mimetic candidate PTG-300 receives fast track designation from the U.S. FDA for development in the treatment of polycythemia vera
2 December 2020 - Protagonist Therapeutics today announced that the U.S. FDA has granted fast track designation to PTG-300 in the ...
Posted by Michael Wonder on 03 Dec 2020
Aeglea BioTherapeutics receives FDA rare paediatric disease designation for ACN00177 for the treatment of homocystinuria
1 December 2020 - Company eligible to receive priority review voucher upon FDA approval of ACN00177. ...
Posted by Michael Wonder on 03 Dec 2020
Moleculin announces FDA approves 3 rare paediatric disease designations for WP1066
1 December 2020 - Moleculin Biotech today announced that the US FDA has approved its request for a rare paediatric ...
Posted by Michael Wonder on 03 Dec 2020
FDA grant fast track designation for remestemcel-L in the treatment of acute respiratory distress syndrome due to COVID-19
2 December 2020 - Mesoblast today announced that the United States FDA has granted fast track designation for remestemcel-L in the ...
Posted by Michael Wonder on 03 Dec 2020
The dawn of digital medicine
2 December 2020 - The pandemic is ushering in the next trillion-dollar industry. ...
Posted by Michael Wonder on 03 Dec 2020
Australia 'ahead of schedule' on COVID-19 vaccine plan
3 December 2020 - Australia could approve a COVID-19 vaccine almost two months ahead of schedule, the head of the ...
Posted by Michael Wonder on 03 Dec 2020
Janssen seeks Health Canada approval for its COVID-19 vaccine
1 December 2020 - Regulator currently evaluating data from 4 vaccine makers. ...
Posted by Michael Wonder on 03 Dec 2020
Pushed to rush, FDA head says feds will get vaccine 'right'
2 December 2020 - The head of the agency responsible for authorising COVID-19 vaccines says it will take the time needed ...
Posted by Michael Wonder on 03 Dec 2020
Incomplete data stalls Swiss authorisation of COVID-19 vaccines
3 December 2020 - Switzerland’s medical regulator Swissmedic says it lacks the necessary information to sign off on three different coronavirus ...
Posted by Michael Wonder on 02 Dec 2020
Trump to meet next week with industry, government officials on COVID vaccine
2 December 2020 - President Donald Trump will gather leaders from industry and government next week for a summit on the ...
Posted by Michael Wonder on 02 Dec 2020
BridgeBio Pharma and Affiliate QED Therapeutics announce FDA acceptance of new drug application for infigratinib for the treatment of cholangiocarcinoma
1 December 2020 - Application will also be submitted for review in Australia and Canada under Project Orbis. ...
Posted by Michael Wonder on 02 Dec 2020
Amicus Therapeutics initiates rolling biologic license application to the U.S. FDA for AT-GAA in late-onset Pompe disease
1 December 2020 - On track for completing the BLA submission in 1H2021. ...
Posted by Michael Wonder on 02 Dec 2020
What the UK's COVID-19 vaccine means for Australia
2 December 2020 - The race for a COVID-19 vaccine appears to have hit the final stretch, with the UK ...
Posted by Michael Wonder on 02 Dec 2020
COVID-19: Australia on track for Pfizer vaccine in March
2 December 2020 - Health Minister Greg Hunt says the UK’s approval of the Pfizer vaccine, to be rolled out from ...